ARMI | BioFabUSA will attend Meeting on the Mesa 2025, one of the premier partnering events for the cell and gene therapy sector, taking place October 6–8 in Phoenix, AZ. This event provides a unique platform for ARMI to engage with leading biotechnology companies, investors, and regulatory experts. As regenerative medicine moves from the lab […]
Hosted by the BioFab Startup Lab, the 2025 BioFab Investment Summit connects early-stage companies with investors and partners driving regenerative medicine forward.
ARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
ARMI will attend RAPID + TCT 2026 to explore the intersection of additive manufacturing and biomanufacturing, driving innovation in regenerative healthcare solutions.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
